Alaunos Therapeutics, Inc. Litigation Settlement, Expense
Alaunos Therapeutics, Inc. (TCRT) had Litigation Settlement, Expense of $1.00 million as of 2023-10-20, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Loss Contingency
us-gaap:LitigationSettlementExpense · last filed 2025-03-31
- 2023-10-20: Litigation Settlement, Expense $1.00M.
| Period end | Litigation Settlement, Expense |
|---|---|
| 2023-10-20 | $1.00M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |